Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability

The summary for the Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.

Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability: The purpose of the research is to develop methods for evaluating the impact of small design differences in the user interface of generic drug-device combination products when compared to the user interface of the reference listed drug (RLD). The results obtained from this research will be used to gain a better understanding of the factors related to small design differences in the user interface that impact substitutability between generic and branded drug-device combination products in end-user groups.

Federal Grant Title:	Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability
Federal Agency Name:	Food and Drug Administration (HHS-FDA)
Grant Categories:	Agriculture Consumer Protection Food and Nutrition
Type of Opportunity:	Discretionary
Funding Opportunity Number:	FOR-FD-20-013
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.103
CFDA Descriptions:	Information not provided
Current Application Deadline:	May 11th, 2021
Original Application Deadline:	May 11th, 2021
Posted Date:	May 25th, 2021
Creation Date:	May 25th, 2021
Archive Date:	May 26th, 2021
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	May 25th, 2021

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Individuals - For-profit organizations other than small businesses - Small businesses
Grant Announcement Contact: Shashi Malhotra
Grants Management Specialist
[email protected]
Similar Government Grants: • Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical T...; • Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U...; • Animal and Veterinary Innovation Centers (U18); • Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food...; • Minor Use Minor Species Development of Drugs (R01); • Support for Small Scientific Conference Grant Program; • Cooperative Agreement to Support the World Health Organization (WHO) International Program...; • Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the Food and Drug Administration: • Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical T...; • Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U...; • Animal and Veterinary Innovation Centers (U18)